Does the immune system see tumors as foreign or self?

Area of Science:

• Cancer immunology
• Tumor microenvironment
• Immunotherapy

Background:

• Carcinogenesis involves numerous genetic and epigenetic alterations, leading to tumor neoantigen expression.
• A key question in cancer immunology is whether immune recognition of tumor antigens results in activation (immune surveillance) or tolerance.
• Established tumors paradoxically induce immune tolerance, despite evidence of immune surveillance in early tumorigenesis.

Purpose of the Study:

• To explore the mechanisms by which established tumors induce immune tolerance.
• To investigate the role of cancer progression processes, such as invasion and metastasis, in modulating the immune response.
• To identify novel strategies for cancer immunotherapy based on understanding immune evasion mechanisms.

Main Methods:

• This study is primarily theoretical, proposing a unifying hypothesis based on existing literature.
• It synthesizes evidence from cancer immunology and tumor biology.
• Focuses on the conceptual framework linking cancer progression to immune evasion.

Main Results:

• Tumor invasion and metastasis are inherently proinflammatory, activating innate and adaptive antitumor immunity.
• Tumors develop mechanisms to block proinflammatory danger signals, shifting the immune balance towards tolerance.
• Elucidation of these immune evasion mechanisms offers new therapeutic avenues.

Conclusions:

• Established tumors actively suppress antitumor immunity by blocking danger signals, despite the proinflammatory nature of cancer progression.
• Understanding these tumor-induced tolerance mechanisms is crucial for developing effective cancer immunotherapies.
• Targeting these evasion strategies could reinvigorate the immune system against established cancers.